title: Induction of antitumor activities in spleen cells from mice and rats activated with lipopolysaccharide immobilized on beads.
abstract: Lipopolysaccharides (LPS) were coupled to polystyrene beads in order to apply the LPS without toxicity. The antitumor activity of the LPS-immobilizing beads was studied in experiments in vitro and in vivo. In vitro studies showed that spleen cells from C3H/HeN mice stimulated by beads immobilizing LPS from Escherichia coli produced cytolytic activity as strong as that of lymphokine-activated killer (LAK) cells. Spleen cells from Sprague-Dawley rats stimulated by beads immobilizing LPS from Salmonella minnesota produced cytolytic activity stronger than that of LAK cells. However, spleen cells stimulated by beads immobilizing each component of the LPS separately could not induce cytolysis. Contact stimulation, even for a brief period, sufficed for cytolytic activity, and was enhanced by culture for 48-72 h. Through in vivo studies, the suppression of tumor growth and a prolongation of the survival time were observed in tumor-bearing mice injected with spleen cells activated by beads immobilizing LPS from E. coli, and in mice injected with LAK cells. The effect of the activated spleen cells was stronger than that of the LAK cells. In rats bearing metastatic tumors, spleen cells activated by beads immobilizing LPS from S. minnesota suppressed lung metastases more strongly than did LAK cells. These findings indicate that LPS immobilized by beads induced killer cells more strongly than interleukin-2. Ex vivo immunomodulation with LPS-immobilizing beads can be applied usefully as an anticancer treatment.
authors.affiliation: First Department of Surgery, Shiga University of Medical Science, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Abe
authors.forename: T
authors.initials: T
authors.lastname: Tani
authors.forename: J
authors.initials: J
authors.lastname: Shibata
authors.forename: M
authors.initials: M
authors.lastname: Kodama
mesh_terms: D000818:Animals; D003602:Cytotoxicity, Immunologic; D004926:Escherichia coli / Q000276:immunology; D007167:Immunotherapy; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology*; D008070:Lipopolysaccharides / Q000737:chemistry / Q000276:immunology*; D008175:Lung Neoplasms / Q000556:secondary; D008213:Lymphocyte Activation; D051379:Mice; D008809:Mice, Inbred C3H; D009362:Neoplasm Metastasis; D009374:Neoplasms, Experimental / Q000473:pathology / Q000628:therapy*; D051381:Rats; D011919:Rats, Inbred Strains; D012475:Salmonella / Q000276:immunology; D013154:Spleen / Q000166:cytology; D016019:Survival Analysis
chemical_list: D008070:Lipopolysaccharides